A Novel Glycolysis and Hypoxia Combined Gene Signature Predicts the Prognosis and Affects Immune Infiltration of Patients with Colon Cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–385. doi:10.3322/caac.21565
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Coller HA. Is cancer a metabolic disease? Am J Pathol. 2014;184(1):4–17. doi:10.1016/j.ajpath.2013.07.035
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:10.1126/science.123.3191.309
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47. doi:10.1016/j.cmet.2015.12.006
   PubMed Web of Science ®Google Scholar
• La Vecchia S, Sebastián C. Metabolic pathways regulating colorectal cancer initiation and progression. Semin Cell Dev Biol. 2020;98:63–70. doi:10.1016/j.semcdb.2019.05.018
   PubMed Web of Science ®Google Scholar
• Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575–580. doi:10.1038/s41586-019-1678-1
   PubMed Web of Science ®Google Scholar
• Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157. doi:10.1186/s12943-019-1089-9
   PubMed Web of Science ®Google Scholar
• Riera-Domingo C, Audigé A, Granja S, et al. Immunity, hypoxia, and metabolism-the ménage à trois of cancer: implications for immunotherapy. Physiol Rev. 2020;100(1):1–102. doi:10.1152/physrev.00018.2019
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, DeBerardinis RJ. Understanding the intersections between metabolism and cancer biology. Cell. 2017;168(4):657–669. doi:10.1016/j.cell.2016.12.039
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14(1):7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Zhou Z, Xie X, Wang X, et al. Correlations between tumor mutation burden and immunocyte infiltration and their prognostic value in colon cancer. Front Genet. 2021;12:623424. doi:10.3389/fgene.2021.623424
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Hong X, Zhong L, Xie Y, et al. Matrine reverses the Warburg effect and suppresses colon cancer cell growth via negatively regulating HIF-1alpha. Front Pharmacol. 2019;10:1437. doi:10.3389/fphar.2019.01437
   PubMed Web of Science ®Google Scholar
• Lu J. The Warburg metabolism fuels tumor metastasis. Cancer Metastasis Rev. 2019;38(1–2):157–164. doi:10.1007/s10555-019-09794-5
   PubMed Web of Science ®Google Scholar
• Kierans SJ, Taylor CT. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol. 2021;599(1):23–37. doi:10.1113/jp280572
   PubMed Web of Science ®Google Scholar
• Peppicelli S, Bianchini F, Calorini L. Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. Cancer Metastasis Rev. 2014;33(2–3):823–832. doi:10.1007/s10555-014-9506-4
   PubMed Web of Science ®Google Scholar
• Huang R, Zong X. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: mechanisms in cancer progression. Crit Rev Oncol Hematol. 2017;115:13–22. doi:10.1016/j.critrevonc.2017.04.005
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB. The hypoxia-lactate axis tempers inflammation. Nat Rev Immunol. 2020;20(2):85–86. doi:10.1038/s41577-019-0259-8
   PubMed Web of Science ®Google Scholar
• Sun AJ, Gao HB, Liu G, Ge HF, Ke ZP, Li S. Identification of MSX1 and DCLK1 as mRNA biomarkers for colorectal cancer detection through DNA methylation information. J Cell Physiol. 2017;232(7):1879–1884. doi:10.1002/jcp.25733
   PubMed Web of Science ®Google Scholar
• Song G, Xu S, Zhang H, et al. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway. J Exp Clin Cancer Res. 2016;35(1):148. doi:10.1186/s13046-016-0427-7
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Q, Zhao L, et al. A combined four-mRNA signature associated with lymphatic metastasis for prognosis of colorectal cancer. J Cancer. 2020;11(8):2139–2149. doi:10.7150/jca.38796
   PubMed Web of Science ®Google Scholar
• Zhang C, Gou X, He W, Yang H, Yin H. A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer. Cancer Cell Int. 2020;20(1):177. doi:10.1186/s12935-020-01255-2
   PubMed Web of Science ®Google Scholar
• Chen C, Shi Y, Li Y, et al. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma. J Genet Genomics. 2017;44(11):519–530. doi:10.1016/j.jgg.2017.05.007
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu J, Huang W, et al. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. J Transl Med. 2020;18(1):201. doi:10.1186/s12967-020-02366-0
   PubMed Web of Science ®Google Scholar
• Brooks JM, Menezes AN, Ibrahim M, et al. Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancer. Clin Cancer Res. 2019;25(17):5315–5328. doi:10.1158/1078-0432.Ccr-18-3314
   PubMed Web of Science ®Google Scholar
• J-aA H, Chang H-C, Neng-Yao S, et al. Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor. Anal Chem. 2010;82(14):5944–5950. doi:10.1021/ac1001959
   PubMed Web of Science ®Google Scholar
• Park C, Lee Y, Je S, et al. Overexpression and selective anticancer efficacy of ENO3 in STK11 mutant lung cancers. (0219-1032 (Electronic)). Mol Cells. 2019;42(11):804. doi:10.14348/molcells.2019.0099
   PubMed Web of Science ®Google Scholar
• Isgrò MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. (0065-2598 (Print)). Adv Cancer Biomark. 2015;125–143. doi:10.1007/978-94-017-7215-0_9
   Google Scholar
• Xie X, Zhao J, Xie L, et al. Identification of differentially expressed proteins in the injured lung from zinc chloride smoke inhalation based on proteomics analysis. Respir Res. 2019;20(1):36. doi:10.1186/s12931-019-0995-0
   PubMed Web of Science ®Google Scholar
• Zhang B, Chamba Y, Shang P, et al. Comparative transcriptomic and proteomic analyses provide insights into the key genes involved in high-altitude adaptation in the Tibetan pig. Sci Rep. 2017;7(1):3654. doi:10.1038/s41598-017-03976-3
   PubMed Web of Science ®Google Scholar
• Yeung BH, Law Ay Fau - Wong CKC, Wong CK. Evolution and roles of stanniocalcin. (1872-8057 (Electronic)). Mol Cell Endocrinol. 2012;349(2):272–280. doi:10.1016/j.mce.2011.11.007
   PubMed Web of Science ®Google Scholar
• Alice YS Law, Keng P Lai, Carman KM Ip, Alice ST Wong, Graham F Wagner, Chris KC Wong. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. (0014-4827 (Print)). Exp Cell Res. 2008;314(8):1823–1830. doi:10.1016/j.yexcr.2008.03.001
   PubMed Web of Science ®Google Scholar
• Chen F, Zhang Z, Pu F. Role of stanniocalcin-1 in breast cancer. Oncol Lett. 2019;18(4):3946–3953. doi:10.3892/ol.2019.10777
   PubMed Web of Science ®Google Scholar
• Law AY, Wong CK. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. (1090-2422 (Electronic)). Exp Cell Res. 2010;316(3):466–476. doi:10.1016/j.yexcr.2009.09.018
   PubMed Web of Science ®Google Scholar
• Calvi A, Wong ASW, Wright G, et al. SUN4 is essential for nuclear remodeling during mammalian spermiogenesis. Dev Biol. 2015;407(2):321–330. doi:10.1016/j.ydbio.2015.09.010
   PubMed Web of Science ®Google Scholar
• Ji Y, Jiang J, Huang L, et al. Sperm‑associated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma. Oncol Rep. 2018. doi:10.3892/or.2018.6473
   Web of Science ®Google Scholar
• Kennedy C, Sebire K, de Kretser DM, O’Bryan MK. Human sperm associated antigen 4 (SPAG4) is a potential cancer marker. Cell Tissue Res. 2004;315(2):279–283. doi:10.1007/s00441-003-0821-2
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Liu F. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma. Int J Mol Med. 2018;42(6):3105–3114. doi:10.3892/ijmm.2018.3899
   PubMed Web of Science ®Google Scholar
• Zhao J, Liu B, Yang JA, Tang D, Wang X, Chen Q. Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis. (1473-558X (Electronic)). Neuroreport. 2019;30(6):446–451. doi:10.1097/WNR.0000000000001226
   PubMed Web of Science ®Google Scholar
• Okolicsanyi RK, van Wijnen AJ, Cool SM, Stein GS, Griffiths LR, Haupt LM. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity. J Cell Biochem. 2014;115(5):967–976. doi:10.1002/jcb.24746
   PubMed Web of Science ®Google Scholar
• Frampton AE, Prado MM, López-Jiménez E, et al. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden. Oncotarget. 2018;9(27):19006–19013. doi:10.18632/oncotarget.24873
   PubMedGoogle Scholar
• Lucien F, Lac V, Billadeau DD, Borgida A, Gallinger S, Leong HS. Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases. Oncotarget. 2019;10(10):1045–1055. doi:10.18632/oncotarget.26620
   PubMedGoogle Scholar
• Saito T, Sugiyama K, Hama S, et al. High expression of glypican-1 predicts dissemination and poor prognosis in glioblastomas. World Neurosurg. 2017;105:282–288. doi:10.1016/j.wneu.2017.05.165
   PubMed Web of Science ®Google Scholar
• Zhang Z, Coomans C, David G. Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the “cooperative end structures” model. J Biol Chem. 2001;276(45):41921–41929. doi:10.1074/jbc.M106608200
   PubMed Web of Science ®Google Scholar
• Li C, Du X, Tai S, et al. GPC1 regulated by miR-96-5p, rather than miR-182-5p, in inhibition of pancreatic carcinoma cell proliferation. Int J Mol Sci. 2014;15(4):6314–6327. doi:10.3390/ijms15046314
   PubMed Web of Science ®Google Scholar
• Chamorro-Jorganes A, Araldi E, Rotllan N, Cirera-Salinas D, Suárez Y. Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells. J Cell Sci. 2014;127(Pt 6)):1169–1178. doi:10.1242/jcs.130518
   PubMed Web of Science ®Google Scholar
• Li J, Li B, Ren C, et al. The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients. Oncotarget. 2017;8(60):101189–101202. doi:10.18632/oncotarget.20516
   PubMedGoogle Scholar
• Gilkes DM, Bajpai S, Chaturvedi P, Wirtz D, Semenza GL. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J Biol Chem. 2013;288(15):10819–10829. doi:10.1074/jbc.M112.442939
   PubMed Web of Science ®Google Scholar
• Duan Y, Dong Y, Dang R, et al. MiR-122 inhibits epithelial mesenchymal transition by regulating P4HA1 in ovarian cancer cells. Cell Biol Int. 2018;42(11):1564–1574. doi:10.1002/cbin.11052
   PubMed Web of Science ®Google Scholar
• Li M, Wu F, Zheng Q, Wu Y, Wu Y. Identification of potential diagnostic and prognostic values of P4HA1 expression in lung cancer, breast cancer, and head and neck cancer. DNA Cell Biol. 2020;39(5):909–917. doi:10.1089/dna.2019.5170
   PubMed Web of Science ®Google Scholar